000			05221nam a22004215i 4500
999			_c368060 _d368060 _x1
001			368060
003			ES-MaUEC
005			20230102121703.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			220208s2021 si | s |||| 0|eng d
020			_a9789811645587
024	7		_a10.1007/978-981-16-4558-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aQP356 _b2021 EB
245	1	0	_aAutism Spectrum Disorder and Alzheimer's Disease : _bAdvances in Research _cedited by Ghulam Md Ashraf, Athanasios Alexiou.
250			_aFirst edition 2021
264		1	_aSingapore _bSpringer International Publishing _c2021
300			_a1 recurso en línea (XI, 314 páginas) _b1 ilustraciones
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_aChapter 1. Behavioral pathophysiology and psychological implications for sleep disorder in dementia -- Chapter 2. Mitochondrial dysfunction is a key player in the pathogenesis of autism spectrum disorders and Alzheimer's disease -- Chapter 3. The pathogenesis and complications associated with autism spectrum disorder and Alzheimer 's disease: A Comparative study -- Chapter 4. Impact of common natural compound in the treatment of Alzheimer's disease -- Chapter 5. Mapping a link between mercury-toxicity and Alzheimer disease -- Chapter 6. Drug therapy of Alzheimer's disease: Cholinesterase inhibitors, NMDA Antagonists -- Chapter 7. Therapeutic potential of polyphenols in Alzheimer's therapy: Broad-spectrum and minimal side effects as key aspects -- Chapter 8. recent advances in Alzheimer's disease in relation to cholinesterase inhibitors and NMDA receptor antagonists -- Chapter 9. Genetic basis of psychotic illnesses: A comprehensive overview RNA Secondary structures in neurodegeneration -- Chapter 10. RNA secondary structures in neurodegeneration -- Chapter 11. Immunotherapy: An approach to treat Alzheimer's disease and autism spectrum disorders -- Chapter 12. Alzheimer's disease (AD) - Physiological barriers for therapy and Nanotechnological applications in the treatment -- Chapter 13. Autism spectrum disorder relationship between sleep and behavior: The effect of sleep variability exploration -- Chapter 14. Role of impaired ABC transporters in Alzheimer's disease -- Chapter 15. Cognitive impairment and rehabilitation of children and adults with autism spectrum disorder.
520			_aThis book talks about the multidimensional biological etiology of Alzheimer's disease and autism spectrum disorder which leads to distinctive ways of perception, thinking and learning in affected individuals. It provides a deeper emphasis on the need for early diagnosis, continuous assessment of patients and the proper educational methods and environment required towards enabling people affected with these disorders capable of evolving and learning. This book explores alternative solutions for autism spectrum disorder based on the theory of brain plasticity, the relationship between the gut microbiota and the central nervous system along with genetic factors and toxic metal exposures which are responsible for the oxidative damage resulting in a decreased ability of the patients to use objects or response to auditory stimuli. It also identifies and provides the latest research towards dealing with memory loss, which is the first sign of cognitive impairment followed by behavioral disturbances. These symptoms are associated with a rigorous neuronal decline and the appearance of two brain lesions, senile plaques and neurofibrillary tangles, which are mainly composed of Aβ and hyper phosphorylated tau protein respectively. This book also provides the latest research towards reducing autism disorder severity such as targeting the disease with symptomatic treatments such as cholinesterase inhibitors, NMDA receptor antagonist, β-secretase and γ-secretase inhibitors, α-secretase stimulators, tau inhibitors, immunotherapy, nutraceuticals, and nano drugs. This book will not only be a good resource for professors and lecturers teaching in the area of neuroscience, medicine, biochemistry, neuroinformatics, and nanotechnology, etc. but also for professionals working in the field of occupational therapy and geriatric clinics and rehabilitation.
988			_aSpringer_BiomedLife_2022
650		7	_2embne _aNeurociencias _9158907
700			_aMd Ashraf, Ghulam _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _9683515
700			_aAlexiou, Athanasios _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _993573
776	0	8	_iPrinted edition: _z9789811645570
776	0	8	_iPrinted edition: _z9789811645594
776	0	8	_iPrinted edition: _z9789811645600
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-16-4558-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b04/2022 _dz _ep _zSI